CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300409740
- Phone
- (415) 651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-18 | Harmon Cyrus Director | Sale | −10,000 | $8.33 | $83K | 744,140 |
| 2025-09-18 | Harmon Cyrus Director | Sale | −3,086 | $8.32 | $26K | 117,028 |
| 2025-09-16 | Harmon Cyrus Director | Sale | −10,000 | $8.04 | $80K | 754,140 |
| 2025-09-16 | Harmon Cyrus Director | Sale | −1,914 | $8.08 | $15K | 120,114 |
| 2025-06-11 | Larson Yi Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | Garland J. Scott Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | Horning Sandra Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | CLARK IAN T Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | Hrustanovic Gorjan Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | Graham G. Walmsley Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | Harmon Cyrus Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | RAPPAPORT ANDREW Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2025-06-11 | BVF PARTNERS L P/IL Director | Grant or award · Stock Option (Right to buy) | +24,150 | 24,150 | ||
| 2025-02-28 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Grant or award · Stock Option (Right to Buy) | +205,000 | 205,000 | ||
| 2025-02-28 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +205,000 | 205,000 | ||
| 2025-02-28 | Mitchell Shawnte CHIEF LEGAL OFFICER | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2025-02-28 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | ||
| 2025-02-28 | Bohen Sean PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2025-01-10 | BVF PARTNERS L P/IL Director | Returned to the company | −235,450 | 2,655,977 |
Page 5 of 11 · 207 trades